These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 323542)

  • 1. [C peptide and pro-insulin].
    Kuzuya H
    Nihon Rinsho; 1977 Feb; 35(2):235-41. PubMed ID: 323542
    [No Abstract]   [Full Text] [Related]  

  • 2. [The occurrence of proinsulin and C-peptide in healthy humans and in diabetics].
    Beischer W
    Fortschr Med; 1982 Sep; 100(33):1508-12. PubMed ID: 7129312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin, C-peptide, and proinsulin in nondiabetics and insulin-treated diabetics. Characterization of the proinsulin in insulin-treated diabetics.
    Heding LG
    Diabetes; 1978; 27 Suppl 1():178-83. PubMed ID: 631439
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood CPR levels in diabetes mellitus during insulin therapy, with special reference to the characteristics of PLC (proinsulin-like components) and C-peptide in fractional analysis].
    Oyama H; Nakajima Y; Amagu A; Matsumura S; Nishida S
    Horumon To Rinsho; 1977 Oct; 25(10):1107-12. PubMed ID: 589809
    [No Abstract]   [Full Text] [Related]  

  • 5. C-peptide and proinsulin after oral glucose.
    Heding LG; Kasperska-Czyzykowa T
    Acta Med Scand Suppl; 1980; 639():33-6. PubMed ID: 6999837
    [No Abstract]   [Full Text] [Related]  

  • 6. [Human C-peptide: radioimmunologic assay and physiopathological applications].
    Nyomba BL; Bouillon R; De Moor P
    Acta Clin Belg; 1980; 35(5):314-23. PubMed ID: 7194562
    [No Abstract]   [Full Text] [Related]  

  • 7. [A radioimmunoassay of human proinsulin C-peptide immunoreactivity and its clinical applications (author's transl)].
    Oyama H; Tenku A; Nakashima Y; Matsumura S; Nishida S
    Rinsho Byori; 1975 Nov; 23(11):850-5. PubMed ID: 1239567
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical significance of circulating C-peptide in diabetes mellitus and hypoglycemic disorders.
    Rubenstein AH; Kuzuya H; Horwitz DL
    Arch Intern Med; 1977 May; 137(5):625-32. PubMed ID: 193451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [C-peptide from proinsulin e--theory and practice].
    Malmquist J; Lindgärde F; Almér LO; Johansson E
    Lakartidningen; 1982 Jul; 79(30-31):2716-9. PubMed ID: 6755106
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevation of C-peptide immunoreactivity in plasma of normal subjects after trypsin action.
    Beck B; Villaume C; Debry G
    Diabete Metab; 1980 Mar; 6(1):25-9. PubMed ID: 6989659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proinsulin, C-peptide reactive protein (CPR)].
    Takahashi R; Oka Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():488-92. PubMed ID: 16149558
    [No Abstract]   [Full Text] [Related]  

  • 12. Proinsulin and C-peptide in diabetes.
    Horwitz DL; Rubenstein AH; Steiner DF
    Med Clin North Am; 1978 Jul; 62(4):723-33. PubMed ID: 98676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical value of C-peptide assay (author's transl)].
    Vialettes B; Vague P
    Diabete Metab; 1980 Sep; 6(3):225-9. PubMed ID: 7002655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a common standard for comparison of insulin C-peptide measurements by different laboratories.
    Caygill CP; Gaines Das RE; Bangham DR
    Diabetologia; 1980 Mar; 18(3):197-204. PubMed ID: 6245983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secretion of c-peptide and its changes in the blood--introduction].
    Horino M; Oyama H
    Horumon To Rinsho; 1977 Oct; 25(10):1059-65. PubMed ID: 338208
    [No Abstract]   [Full Text] [Related]  

  • 16. Heterogeneity of circulating insulin and proinsulin in man.
    Horwitz DL; Rubenstein AH
    Isr J Med Sci; 1974 Oct; 10(10):1201-11. PubMed ID: 4373412
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis of insulinomas. Determination of insulin, C-peptide and proinsulin in blood to differentiate between endogenous and exogenous hyperinsulinism].
    Hanssen KF; Torjesen PA; Heding LG
    Tidsskr Nor Laegeforen; 1981 Dec; 101(34-36):1957-60. PubMed ID: 6280336
    [No Abstract]   [Full Text] [Related]  

  • 18. [Factitious hypoglycaemia in an insulin-dependent diabetic: the value of the estimation of immunoreactive C peptide and insulin blood levels (author's transl)].
    Boyer J; Rohmer V; Davert A; Joubaud F
    Nouv Presse Med; 1979 Jul 14-28; 8(32):2627. PubMed ID: 493062
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas.
    Turner RC; Heding LG
    Diabetologia; 1977 Dec; 13(6):571-7. PubMed ID: 201531
    [No Abstract]   [Full Text] [Related]  

  • 20. [Usefulness of the determination of C-peptide and proinsulin in the extrahepatic serum for the evaluation of the function of the B cells of the islands of Langerhans].
    Czyzyk A
    Pol Arch Med Wewn; 1983; 69(4-5):249-57. PubMed ID: 6356053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.